View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 7, 2018updated 27 Jul 2022 5:24pm

Johnson & Johnson to compensate faulty hip implant patients in India

Johnson & Johnson (J&J) has agreed to work with the Indian government to offer compensation to patients who were affected by faulty hip implants.

Johnson & Johnson (J&J) has agreed to work with the Indian government to offer compensation to patients who were affected by faulty hip implants.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

DePuy International, a unit of J&J, sold the implant known as DePuy ASR in India before it was recalled in 2010 after data indicated they failed at a higher-than-expected rate.

“Johnson & Johnson has been recommended to pay a base compensation of Rs2m ($27842) to each patient.”

Last month the Central Drugs Standard Control Organization (CDSCO) asked the company to compensate all the patients who were fitted with articular surface replacement (ASR) implant.

The government -appointed committee recommended a base compensation of Rs2m ($27842) to each patient.

It is estimated that nearly 4,500 patients were fitted with the recalled device before they were recalled.

A Johnson & Johnson spokeswoman in a statement emailed to Reuters said: “We have always been and continue to be fully committed to supporting all ASR patients in India, and the rest of the world.

“In light of the recent committee report, we are seeking to work with the Indian government to develop an appropriate process for providing further support and compensation for patients in need,” she added.

However, there is no confirmation on whether the company will pay the recommended compensation to each patient or is in plans to negotiate the amount with the government, reported the news agency.

In 2013, Johnson & Johnson agreed to pay nearly $2.5bn in the US to settle thousands of lawsuits from patients who complained that they were affected by the implants.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network